221 related articles for article (PubMed ID: 32847068)
1. Histone Demethylase LSD1 Regulates Kidney Cancer Progression by Modulating Androgen Receptor Activity.
Lee KH; Kim BC; Jeong SH; Jeong CW; Ku JH; Kwak C; Kim HH
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847068
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of lysine-specific demethylase 1 promotes androgen-independent transition of human prostate cancer LNCaP cells through activation of the AR signaling pathway and suppression of the p53 signaling pathway.
Li X; Li T; Chen D; Zhang P; Song Y; Zhu H; Xiao Y; Xing Y
Oncol Rep; 2016 Jan; 35(1):584-92. PubMed ID: 26534764
[TBL] [Abstract][Full Text] [Related]
4. Histone demethylase KDM7A controls androgen receptor activity and tumor growth in prostate cancer.
Lee KH; Hong S; Kang M; Jeong CW; Ku JH; Kim HH; Kwak C
Int J Cancer; 2018 Dec; 143(11):2849-2861. PubMed ID: 30183076
[TBL] [Abstract][Full Text] [Related]
5. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription.
Metzger E; Wissmann M; Yin N; Müller JM; Schneider R; Peters AH; Günther T; Buettner R; Schüle R
Nature; 2005 Sep; 437(7057):436-9. PubMed ID: 16079795
[TBL] [Abstract][Full Text] [Related]
6. Cryptotanshinone down-regulates androgen receptor signaling by modulating lysine-specific demethylase 1 function.
Wu CY; Hsieh CY; Huang KE; Chang C; Kang HY
Int J Cancer; 2012 Sep; 131(6):1423-34. PubMed ID: 22052438
[TBL] [Abstract][Full Text] [Related]
7. C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion.
Yue D; Wang Y; Sun Y; Niu Y; Chang C
Neoplasia; 2017 Feb; 19(2):135-144. PubMed ID: 28107702
[TBL] [Abstract][Full Text] [Related]
8. Dihydrotestosterone promotes kidney cancer cell proliferation by activating the STAT5 pathway via androgen and glucocorticoid receptors.
Pak S; Kim W; Kim Y; Song C; Ahn H
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2293-2301. PubMed ID: 31401673
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.
Metzger E; Imhof A; Patel D; Kahl P; Hoffmeyer K; Friedrichs N; Müller JM; Greschik H; Kirfel J; Ji S; Kunowska N; Beisenherz-Huss C; Günther T; Buettner R; Schüle R
Nature; 2010 Apr; 464(7289):792-6. PubMed ID: 20228790
[TBL] [Abstract][Full Text] [Related]
10. Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer.
Kauffman EC; Robinson BD; Downes MJ; Powell LG; Lee MM; Scherr DS; Gudas LJ; Mongan NP
Mol Carcinog; 2011 Dec; 50(12):931-44. PubMed ID: 21400613
[TBL] [Abstract][Full Text] [Related]
11. Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor.
Willmann D; Lim S; Wetzel S; Metzger E; Jandausch A; Wilk W; Jung M; Forne I; Imhof A; Janzer A; Kirfel J; Waldmann H; Schüle R; Buettner R
Int J Cancer; 2012 Dec; 131(11):2704-9. PubMed ID: 22447389
[TBL] [Abstract][Full Text] [Related]
12. CACUL1 functions as a negative regulator of androgen receptor in prostate cancer cells.
Choi H; Lee SH; Um SJ; Kim EJ
Cancer Lett; 2016 Jul; 376(2):360-6. PubMed ID: 27085459
[TBL] [Abstract][Full Text] [Related]
13. Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells.
Lee KH; Kim BC; Jeong SH; Jeong CW; Ku JH; Kim HH; Kwak C
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781788
[TBL] [Abstract][Full Text] [Related]
14. Lysine-specific demethylase 1 has dual functions as a major regulator of androgen receptor transcriptional activity.
Cai C; He HH; Gao S; Chen S; Yu Z; Gao Y; Chen S; Chen MW; Zhang J; Ahmed M; Wang Y; Metzger E; Schüle R; Liu XS; Brown M; Balk SP
Cell Rep; 2014 Dec; 9(5):1618-1627. PubMed ID: 25482560
[TBL] [Abstract][Full Text] [Related]
15. LSD1 Inhibition Disrupts Super-Enhancer-Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer.
Li M; Liu M; Han W; Wang Z; Han D; Patalano S; Macoska JA; Balk SP; He HH; Corey E; Gao S; Cai C
Cancer Res; 2023 May; 83(10):1684-1698. PubMed ID: 36877164
[TBL] [Abstract][Full Text] [Related]
16. LSD1 deletion represses gastric cancer migration by upregulating a novel miR-142-5p target protein CD9.
Zhao LJ; Fan QQ; Li YY; Ren HM; Zhang T; Liu S; Maa M; Zheng YC; Liu HM
Pharmacol Res; 2020 Sep; 159():104991. PubMed ID: 32504836
[TBL] [Abstract][Full Text] [Related]
17. The combined effect of epigenetic inhibitors for LSD1 and BRD4 alters prostate cancer growth and invasion.
Wang J; Yu Q; Qiu Z; Dai T; Wang S; Yang X; Evers BM; Wu Y
Aging (Albany NY); 2020 Jan; 12(1):397-415. PubMed ID: 31901895
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling.
Guan Z; Li C; Fan J; He D; Li L
Sci Rep; 2016 Nov; 6():37085. PubMed ID: 27848972
[TBL] [Abstract][Full Text] [Related]
19. HOTAIR and androgen receptor synergistically increase GLI2 transcription to promote tumor angiogenesis and cancer stemness in renal cell carcinoma.
Bai JY; Jin B; Ma JB; Liu TJ; Yang C; Chong Y; Wang X; He D; Guo P
Cancer Lett; 2021 Feb; 498():70-79. PubMed ID: 33157157
[TBL] [Abstract][Full Text] [Related]
20. LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer.
Battaglia S; Karasik E; Gillard B; Williams J; Winchester T; Moser MT; Smiraglia DJ; Foster BA
Clin Epigenetics; 2017; 9():82. PubMed ID: 28811844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
